Last checked at 
Tekcapital PLC - London-based intellectual property investor - Sells 3.5 million shares in AIM-listed medical device developer Belluscura PLC at a price of 16.15 pence each, raising GBP565,250. Following the share sale, Tekcapital owns 7.7% of Belluscura.
Tekcapital says it will use the proceeds of the Belluscura share sale to contribute towards the initial public offering on AIM of MicroSalt PLC, of which it currently owns 87%. MicroSalt has been planning the IPO for over a year now, with the date put back three times so far, most recently to "late January".
Tekcapital current stock price: 7.20p, down 4.0%
12-month change: down 61%
Belluscura current stock price: 19.80p, up 2.1%
12-month change: down 54%
By Greg Rosenvinge, Alliance News senior reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
